The Role of the Key Differentially Mutated Gene FGFR3 in the Immune Microenvironment of Bladder Cancer

Table 1

Statistics of clinicopathological characteristics of bladder cancer cases.

	Overall
	408
Futime (mean (SD))	757.33 (813.00)
(%)	157 (38.5)
Age (mean (SD))	68.08 (10.61)
(%)	301 (73.8)
Grade (%)
High grade	384 (94.1)
Low grade	21 (5.1)
Unknown	3 (0.7)
Stage (%)
Stage I	2 (0.5)
Stage II	130 (31.9)
Stage III	140 (34.3)
Stage IV	134 (32.8)
Unknown	2 (0.5)
T (%)
T0	1 (0.2)
T1	3 (0.7)
T2	38 (9.3)
T2a	25 (6.1)
T2b	56 (13.7)
T3	43 (10.5)
T3a	70 (17.2)
T3b	81 (19.9)
T4	10 (2.5)
T4a	43 (10.5)
T4b	5 (1.2)
TX	1 (0.2)
Unknown	32 (7.8)
M (%)
M0	196 (48.0)
M1	11 (2.7)
MX	198 (48.5)
Unknown	3 (0.7)
N (%)
N0	237 (58.1)
N1	46 (11.3)
N2	75 (18.4)
N3	8 (2.0)
NX	36 (8.8)
Unknown	6 (1.5)